GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Renata PLC (DHA:RENATA) » Definitions » Selling and Marketing Expense

Renata (DHA:RENATA) Selling and Marketing Expense : BDT5,447 Mil (TTM As of Dec. 2024)


View and export this data going back to . Start your Free Trial

What is Renata Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Renata's Selling and Marketing Expense for the three months ended in Dec. 2024 was BDT2,841 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Dec. 2024 was BDT5,447 Mil.

Renata Selling and Marketing Expense Historical Data

The historical data trend for Renata's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Renata Selling and Marketing Expense Chart

Renata Annual Data
Trend Dec14 Dec15 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Selling and Marketing Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2,793.82 3,533.20 2,879.94 4,130.03 5,430.65

Renata Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Selling and Marketing Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,473.03 - - 2,606.72 2,840.78

Renata Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was BDT5,447 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Renata Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Renata's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Renata Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Renata PLC (DHA:RENATA) » Definitions » Selling and Marketing Expense
Comparable Companies
DHA:BXPHARMA DHA:ACMELAB DHA:ORIONINFU DHA:ASIATICLAB DHA:TECHNODRUG DHA:CENTRALPHL DHA:SQURPHARMA ZTS XTER:MRK LSE:HLN NSE:SUNPHARMA TSE:4502 XSWX:GALD XSWX:SDZ NSE:DIVISLAB HKSE:03692 XTAE:TEVA SHSE:688506 BOM:500087 SZSE:000538
Traded in Other Exchanges
N/A
Address
Plot Number 1, Milk Vita Road, Section-7, GPO Box No. 303, Mirpur, Dhaka, BGD, 1216
Website
https://www.renata-ltd.com
Renata PLC is a Bangladesh based pharmaceutical company. It is engaged in the manufacturing, marketing, and distribution of Human Pharmaceuticals, Animal Health Medicines, Nutritionals, and Vaccines. It manufactures various pharmaceutical products including Beconex Zi Syrup, Cabolin Tablet, Flontin Tablet, Ivana Tablet, and others. Some of the animal health products offered by the company are Doxivet Powder, Fevenil Injection, Diadin Bolus, Renamet Tablet, and others. The company operates in Bangladesh and sells its products locally and internationally.

Renata Headlines

No Headlines